Node negative breast cancer.
- 10 February 1990
- Vol. 300 (6721), 346-348
- https://doi.org/10.1136/bmj.300.6721.346
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Prolonged Disease-Free Survival after One Course of Perioperative Adjuvant Chemotherapy for Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast CancerNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative TumorsNew England Journal of Medicine, 1989
- Proliferative index of breast carcinoma by thymidine labeling: Prognostic power independent of stage, estrogen and progesterone receptorsBreast Cancer Research and Treatment, 1988
- Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancerBreast Cancer Research and Treatment, 1986
- Clinical trials on adjuvant chemotherapy for breast cancerCancer, 1986
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerBreast Cancer Research and Treatment, 1985
- Comment on ‘Interobserver reproducibility of histopathological features in Stage II breast cancer’, by KW Gilchrist et al.Breast Cancer Research and Treatment, 1985
- Interobserver reproducibility of histopathological features in stage II breast cancerBreast Cancer Research and Treatment, 1985